Your SlideShare is downloading. ×

Amap Overview 2010

120

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
120
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Association of Medical Affairs Professionals Overview
  • 2. Ver. SK062510CP Organization • Non-profit organization supporting Medical Affairs professionals in Pharmaceutical, Biotechnology and Medical Device Companies
  • 3. Ver. SK062510CP Mission Sharing of best practices • Advocacy: – Set a stage for appropriate medical communications between medical professionals within pharmaceutical companies and physicians 3
  • 4. Ver. SK062510CP Mission Sharing of best practices • Provide a platform for education and professional development for the membership – Create and establish understanding of what medical affairs function is all about 4
  • 5. Ver. SK062510CP Mission Sharing of best practices • Self interest and higher interest – Self interest: training, articles, journals, best practice sharing, networking – Higher interest: scientific communication, ensuring that physicians understand the role of medical affairs, looking for innovative ways of doing studies 5
  • 6. Ver. SK062510CP Management • Operating Board of Directors – Elected – two year term – Each board seat focused on specific areas of the organization – Chairperson • Elected – two year term • Executive Board – Invited – Two year Term 6
  • 7. Ver. SK062510CP Current Status • Filing for 501(c)3 non profit status • Expanded enrollment to begin late 2010 • Started Process of Setting up European Executive Board ©2010 Skila, a Sela2 Company. All Rights Reserved. Proprietary and Confidential. 7
  • 8. Ver. SK062510CP Executive Committee ©2010 Skila, a Sela2 Company. All Rights Reserved. Proprietary and Confidential. 8 Simon Mason Skila Dr. Steven James Allergan Kathy Presto Roche Dr. Ken Newman Medical Affairs Consultant – former Boehringer Ingelheim/Forest Shahin Gharakhanian Vertex Pharma Dr. Charles Hugh-Jones Sanofi-Aventis Dr. William Sigmund GSK Dr. Paul Weber PTC Biotech

×